Results 201 to 210 of about 144,610 (311)

Neoadjuvant therapy in skin cancer: current evidence and future perspectives. [PDF]

J Dtsch Dermatol Ges
Daniello L, Kleemann J, Schilling B.
europepmc   +1 more source

Laparoscopic Resection of Caudate Lobe Liver Tumors in Clinical Practice

iNew Medicine, EarlyView.
ABSTRACT The caudate lobe (Couinaud segment I), owing to its deep location in the posterosuperior liver, intimate encirclement by the inferior vena cava (IVC), and close adjacency to the hepatic hilum and major hepatic veins, presents a formidable anatomical challenge for resection.
Dingde Ye, Wenjie Zhang, Qiaoyu Liu, Beicheng Sun, Qingxiang Xu   +4 more
wiley   +1 more source

Statin use and oncologic outcomes following neoadjuvant therapy for esophageal cancer. [PDF]

J Thorac Dis
van der Aa DC, Anderegg MCJ, Bergman JJGHM, Meijer SL, Lagarde SM, van Berge Henegouwen MI, van Laarhoven HWM, Gisbertz SS.   +7 more
europepmc   +1 more source

Ovarian Cancer: Epidemiology, Disease Mechanisms, New Diagnosis and Treatment Strategies, and Research Directions

iNew Medicine, EarlyView.
ABSTRACT Ovarian cancer (OC) continues to be the deadliest gynecological malignancy and a significant cause of cancer‐related mortality among women worldwide. Standard treatment strategies typically entail platinum‐based chemotherapy in conjunction with cytoreductive surgery.
Zunera Khalid, Weirong Fan, Farah Nazir, Yixiang Xing, Tengchuan Jin   +4 more
wiley   +1 more source

Neoadjuvant therapy in resectable and borderline resectable pancreatic cancer-safe but standard of care? [PDF]

Gland Surg
Lee JJ, Desai CS, Kim HJ.
europepmc   +1 more source

Neoadjuvant Therapy

Annals of Surgery, 1999
openaire   +2 more sources

Black phosphorus‐based photothermal disruption of cancer‐associated fibroblast barriers and tumor‐associated macrophage targeting to enhance anti‐PD‐L1 immunotherapy in triple‐negative breast cancer

Interdisciplinary Medicine, EarlyView.
MBB modulates the TNBC tumor microenvironment by targeting TAM/CXCL1 and facilitates anti‐PD‐L1 therapy by disrupting CAF barriers via its photothermal effect. This combined strategy subsequently enhances the efficacy of PD‐L1 mAb and suppresses TNBC progression, metastasis, and recurrence.
Bo Pan, Shicui Hong, Xinyue Wang, Yanghang Li, Cai Wang, Yaxiao Liu, Ying Chen, Chen Fang, Yifeng Zheng, Shengqi Wang, Juping Zhang, Neng Wang, Zhiyu Wang   +12 more
wiley   +1 more source

A Consensus Approach to the Incorporation of Total Neoadjuvant Therapy in a Treatment Algorithm for Stage I-III Resectable Rectal Cancer. [PDF]

Curr Oncol
Chadi SA, Kazazian K, Savage P, Brezden-Masley C, Burkes R, Chen E, Govindarajan A, Hosni A, Jang R, Kennedy E, Kim J, Lukovic J, Mesci A, O'Brien C, Quereshy F, Salawu A, Stotland PK, Swallow CJ.   +17 more
europepmc   +1 more source

Neoadjuvant Therapy for Malignant Melanoma

This thesis explores the emerging role of neoadjuvant therapy in the management of resectable malignant melanoma. Neoadjuvant approaches using immune checkpoint inhibitors and targeted therapies - offer potential benefit such as early immune activation ...
Shoval, Shahaf
core  

Advanced Molecular Imaging Probes for Skeletal Diseases: Current Progress and Future Perspectives

iRADIOLOGY, EarlyView.
This review summarizes the potential molecular imaging techniques and probes for common orthopedic diseases, such as trauma, infection, metabolism, tumor, joint, spine and other fields, aiming to provide a basis for the development of a new generation of molecular imaging probes.
Shuo Guo, Yuling Cui, Zhiye Fan, Chenxin Jiang, Bowen Fu, Guangbin Cui, Yanli He   +6 more
wiley   +1 more source